Tailor-made strategies to your needs for the investigation of the efficacy of your bacteria-based treatments and/or the effect of your therapies on microbiota. 

Join Dr. Sylvie Maubant and Emilie Soulier to discover how Oncodesign assess the interplay between tumor or inflammatory disease of interest (e.g. colitis), microbiota and therapies.

Our comprehensive platform dedicated to microorganisms helps you to investigate in vitro and/or in vivo the bacteria as immuno-modulating vectors or agents.

Our teams have developed models for pathologies related to microbiota disorders and therefore can customize studies for programs from preclinical to early clinical phases.

We guide you on all projects on bacteria-based therapies or any treatment acting on microbiota across different therapeutic areas i.e. oncology and inflammatory diseases.

I contact Sylvie & Emilie!

I know to know more!